Search results for "slas europe 2018"

This release builds extensively on the Mountains® 7 platform introduced in 2013 and now supplied by most major manufacturers with their instruments

Agilent's flexible, pre-configured and factory-tested Residual Solvent Analyzers provide quick start-up for accurate and reproducible analysis of Class 1 and Class 2A/B solvent content in pharmaceutical products.

Global laboratory informatics leader launches discipline-specific solutions unified by Clinisys Platform™ SaaS architecture and data model

You could win a $500/£400/450 € Amazon Gift Card simply by voting for the laboratory product which most advanced your work last year

Key event for powering the business of science opens on October 31, running to November 1 at the NEC, Birmingham, UK

A celebration of the clinical laboratory products that have made the most difference to your lab work, plus we reveal our most popular clinical interviews of the past year

SelectScience will be attending the AACC Annual Meeting in Chicago, USA, to interview leading scientists and report on the latest technologies

19th Annual European Society for the Clinical Virology (ESCV) meeting in Lisbon, Portugal, 14-17 September 2016

Compatible with Micronic screw caps and ANSI/SLAS standards

Best value in its class for basic weighing tasks

With Boroflo Stopcock, Class A, With Individual Calibration Certificate

New RNA-sequencing kit will improve treatment management decisions for breast cancer patients

The Yourgene Cystic Fibrosis Base assay is a Class C in vitro medical device under IVDR and is intended for use by healthcare professionals within a molecular laboratory environment

Ncardia develops, produces and commercializes highly predictive human cellular assay systems for safety and efficacy testing. The product portfolio encompasses a broad panel of hiPSC derived cryopreserved cardiomyocytes and neurons. In addition, the company delivers the CardioPlateTM product line of quality controlled ready to use assay plates. Using its cell products, Ncardia develops and provides its customers with a broad portfolio of cardiovascular services from safety pharmacology and disease modeling to cardiovascular drug efficacy screening. Ncardia is based in Belgium, The Netherlands, Germany, and the USA. The company is privately held and was established in September 2017 following the merger of Pluriomics and Axiogenesis, two well-known pioneers in the field of stem cell derived cells for safety and toxicology assessment.

Atrandi Biosciences, founded in 2016, is a pioneering life sciences tool company transforming single-cell analysis with its patented Semi-Permeable Capsule (SPC) technology. This next-generation technology isolates tens of thousands of single cells within discrete, permeable compartments, allowing bulk reactions to proceed as usual while preserving single-cell resolution. SPCs have already unlocked previously inaccessible applications, such as high-throughput microbial and eukaryotic genomics, and are poised to enable true single-cell multiomics. Headquartered in Vilnius, Lithuania, Atrandi’s name, meaning “you discover” in Lithuanian, embodies the company’s mission to empower scientists to uncover the unknown and make groundbreaking discoveries. Company Facts: 200+ satisfied customers 150+ install base 20+ collaborations worldwide 65 employees and growing ISO 9001 & ISO 14001 certified